← Insider buys
RARE

Ultragenyx Pharmaceutical Inc. · Healthcare

SVP and Chief Accounting Officer Theodore Alan Huizenga sold $28K of Ultragenyx Pharmaceutical Inc.

Sold$27,733
$43.40Price
639Shares
−4%Stake

What RARE did after the filing

Filed Mar 2, copier in the same day
The stock from Thu, Mar 2 close, $45.05
−15.2%
S&P 500, same days
+4.1%

Measured over 30 trading days, to the Apr 14 close.

Traded Tue, Feb 28. Filed Thu, Mar 2, 2:28 PM ET, during the session. Returns use the Mar 2 close and the Apr 14 close. Not investment advice.